<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="/global/feed/rss.xslt" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" xmlns:podaccess="https://access.acast.com/schema/1.0/" xmlns:acast="https://schema.acast.com/1.0/">
    <channel>
		<ttl>60</ttl>
		<generator>acast.com</generator>
		<title>CELL Talk</title>
		<link>https://shows.acast.com/cell-talk</link>
		<atom:link href="https://feeds.acast.com/public/shows/6140941ffd9dbd0012866cbb" rel="self" type="application/rss+xml"/>
		<language>no</language>
		<copyright>Cell Talk</copyright>
		<itunes:keywords>Helse,Kreft,Onkologi,Blodkreft</itunes:keywords>
		<itunes:author>Cell Talk</itunes:author>
		<itunes:subtitle>Reisen fra forskning til pasient.</itunes:subtitle>
		<itunes:summary><![CDATA[Hematologi teamet i Bristol Myers Squibb oppsøker miljøet for å lære mer om reisen fra forskning til pasient. HE-NO-2100008<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		<description><![CDATA[Hematologi teamet i Bristol Myers Squibb oppsøker miljøet for å lære mer om reisen fra forskning til pasient. HE-NO-2100008<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
		<itunes:explicit>false</itunes:explicit>
		<itunes:owner>
			<itunes:name>Cell Talk</itunes:name>
			<itunes:email>info+6140941ffd9dbd0012866cbb@mg-eu.acast.com</itunes:email>
		</itunes:owner>
		<acast:showId>6140941ffd9dbd0012866cbb</acast:showId>
		<acast:showUrl>cell-talk</acast:showUrl>
		<acast:signature key="EXAMPLE" algorithm="aes-256-cbc"><![CDATA[wbG1Z7+6h9QOi+CR1Dv0uQ==]]></acast:signature>
		<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmQI5cfyaoZT5d8ESYLTxQI/BzBM/AMxuBqA8TYO7/mflIYzAYWPNLJ9XeAfbeuDZgPQt9sA2FE+kQBSXB//vY57T1hZznFEV2RVwZT176vSennVbGCBAe2YXMUu8fofMhiDGqZh+6a2JiNrRVcO6IRiKbQvdSLtyURL3Rfw8DUa7LI9SbRShaLZdVMckwgEeC0fAwJGFcW38dfpEZKL9V96yA5o2wl3blRoXmoe7cY4yRvhsSKTsnT09sETawpB7CF02OOMUzpi1nDJs4FQNdLY=]]></acast:settings>
        <acast:network id="60075d64795a1c638da15021" slug="kjetil-wasteson"><![CDATA[Kjetil Wasteson]]></acast:network>
		<itunes:type>episodic</itunes:type>
			<itunes:image href="https://assets.pippa.io/shows/6140941ffd9dbd0012866cbb/1656411788818-e198d4b095595685c6b9cae88ecb6f44.jpeg"/>
			<image>
				<url>https://assets.pippa.io/shows/6140941ffd9dbd0012866cbb/1656411788818-e198d4b095595685c6b9cae88ecb6f44.jpeg</url>
				<link>https://shows.acast.com/cell-talk</link>
				<title>CELL Talk</title>
			</image>
		<item>
			<title>Talassemi - En pasienthistorie og en norsk ekspert på behandling</title>
			<itunes:title>Talassemi - En pasienthistorie og en norsk ekspert på behandling</itunes:title>
			<pubDate>Wed, 31 Aug 2022 13:05:24 GMT</pubDate>
			<itunes:duration>27:24</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/6140941ffd9dbd0012866cbb/e/62bc528a91779c00120e9ca9/media.mp3" length="39465460" type="audio/mpeg"/>
			<guid isPermaLink="false">62bc528a91779c00120e9ca9</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/cell-talk/episodes/talassemi-en-pasienthistorie-og-en-norsk-ekspert-pa-behandli</link>
			<acast:episodeId>62bc528a91779c00120e9ca9</acast:episodeId>
			<acast:showId>6140941ffd9dbd0012866cbb</acast:showId>
			<acast:episodeUrl>talassemi-en-pasienthistorie-og-en-norsk-ekspert-pa-behandli</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmRbkUlg2iR8fDtnl1O71B2N8B7jZZH+7YdsHlGFxMJ/JB5ewwSWwnDfITsERRlXnRPdjbJm7d4qQ2rUK1Oh2E65gYDhVAjVZ14DHwOhC8Pz9i+jargxr+Z+jVE9yJC778zhTQHU6gZEVV13nQX7pAdNB4u1MbNygBgy4VtStsTGZDTm4svZmzStw+pmjnI3CvDVSxJNi0XoecF251QwStf3FCehPgXi9xT2YyHfevWtyypkBoRTs3uR41wjlyEs56B1wDhMW1Kc1yWuS75SUNN0lLF+QbbvCa5GISizsVHY/Sw7eF4SINF1xOi+aIFL47Q==]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>4</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/6140941ffd9dbd0012866cbb/1656411788818-e198d4b095595685c6b9cae88ecb6f44.jpeg"/>
			<description><![CDATA[<p><br></p><br><p><br></p><p>HE-NO-2200010</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p><br></p><br><p><br></p><p>HE-NO-2200010</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Myelomatose – Anders Waage og Tobias Slørdahl om klinikk og forskning ved St Olavs hospital</title>
			<itunes:title>Myelomatose – Anders Waage og Tobias Slørdahl om klinikk og forskning ved St Olavs hospital</itunes:title>
			<pubDate>Thu, 09 Jun 2022 13:10:06 GMT</pubDate>
			<itunes:duration>46:22</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/6140941ffd9dbd0012866cbb/e/62a1f12e4182ab00131517ae/media.mp3" length="66784590" type="audio/mpeg"/>
			<guid isPermaLink="false">62a1f12e4182ab00131517ae</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/cell-talk/episodes/myelomatose-anders-waage-og-tobias-slrdahl-om-klinikk-og-for</link>
			<acast:episodeId>62a1f12e4182ab00131517ae</acast:episodeId>
			<acast:showId>6140941ffd9dbd0012866cbb</acast:showId>
			<acast:episodeUrl>myelomatose-anders-waage-og-tobias-slrdahl-om-klinikk-og-for</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmRbkUlg2iR8fDtnl1O71B2N8B7jZZH+7YdsHlGFxMJ/JB5ewwSWwnDfITsERRlXnRPdjbJm7d4qQ2rUK1Oh2E65gYDhVAjVZ14DHwOhC8Pz9i+jargxr+Z+jVE9yJC778zhTQHU6gZEVV13nQX7pAdNB4u1MbNygBgy4VtStsTGZDTm4svZmzStw+pmjnI3CvDVSxJNi0XoecF251QwStf3FCehPgXi9xT2YyHfevWtybS+qa9mtqsa6cMRtcT4zGzdJpvoUJ0skE4xEHQRQhlnfSHzaMmzkpFT/mWTJ2dl70LvaQfOcrIyC/NNr4xsMaw==]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>3</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/6140941ffd9dbd0012866cbb/1669127290825-f4ea213fbe62c2242a57371f192966fb.jpeg"/>
			<description><![CDATA[<p>Myelomatose – Anders Waage og Tobias Slørdahl ved St Olavs hospital i samtale med BMS om hvorfor det er viktig å kombinere klinikk og forskning til det beste for pasienten. Hvordan har utviklingen av Myelomatosebehandlingen vært, og hvordan ser fremtiden ut for forskning innen Myelomatose? </p><br><p>HE-NO-2200009</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Myelomatose – Anders Waage og Tobias Slørdahl ved St Olavs hospital i samtale med BMS om hvorfor det er viktig å kombinere klinikk og forskning til det beste for pasienten. Hvordan har utviklingen av Myelomatosebehandlingen vært, og hvordan ser fremtiden ut for forskning innen Myelomatose? </p><br><p>HE-NO-2200009</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Blodkreftforeningen – hvem er de, og hva opptar dem?</title>
			<itunes:title>Blodkreftforeningen – hvem er de, og hva opptar dem?</itunes:title>
			<pubDate>Tue, 22 Mar 2022 09:44:02 GMT</pubDate>
			<itunes:duration>34:21</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/6140941ffd9dbd0012866cbb/e/62399a3c02a7a00012dc81f4/media.mp3" length="49476439" type="audio/mpeg"/>
			<guid isPermaLink="false">62399a3c02a7a00012dc81f4</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/cell-talk/episodes/blodkreftforeningen-hvem-er-de-og-hva-opptar-dem</link>
			<acast:episodeId>62399a3c02a7a00012dc81f4</acast:episodeId>
			<acast:showId>6140941ffd9dbd0012866cbb</acast:showId>
			<acast:episodeUrl>blodkreftforeningen-hvem-er-de-og-hva-opptar-dem</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmRbkUlg2iR8fDtnl1O71B2N8B7jZZH+7YdsHlGFxMJ/JB5ewwSWwnDfITsERRlXnRPdjbJm7d4qQ2rUK1Oh2E65gYDhVAjVZ14DHwOhC8Pz9i+jargxr+Z+jVE9yJC778zhTQHU6gZEVV13nQX7pAdNB4u1MbNygBgy4VtStsTGZDTm4svZmzStw+pmjnI3CvDVSxJNi0XoecF251QwStf3FCehPgXi9xT2YyHfevWtyGwKlYKXxmJc/BGgOmie8aKC6L+p44zuZMeWkLCtPDrWvU39dUXrhLAjW/jUBmJB7tFazVj19IIef1GFDAZhZLw==]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>2</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/6140941ffd9dbd0012866cbb/1669127263177-882ec5ac37d8c807d10a2cd7bd07fb4b.jpeg"/>
			<description><![CDATA[En samtale mellom Olav Ljøsne leder i blodkreftforeningen og BMS, med hovedfokus på Myelomatose. HE-NO-2200005<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[En samtale mellom Olav Ljøsne leder i blodkreftforeningen og BMS, med hovedfokus på Myelomatose. HE-NO-2200005<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Lymfekreft med overlege Alexander Fosså</title>
			<itunes:title>Lymfekreft med overlege Alexander Fosså</itunes:title>
			<pubDate>Wed, 15 Sep 2021 10:23:10 GMT</pubDate>
			<itunes:duration>31:23</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/6140941ffd9dbd0012866cbb/e/6140d4edfd9dbd0012866d2e/media.mp3" length="45214063" type="audio/mpeg"/>
			<guid isPermaLink="false">6140d4edfd9dbd0012866d2e</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/cell-talk/episodes/lymfekreft-med-overlege-alexander-fossa</link>
			<acast:episodeId>6140d4edfd9dbd0012866d2e</acast:episodeId>
			<acast:showId>6140941ffd9dbd0012866cbb</acast:showId>
			<acast:episodeUrl>lymfekreft-med-overlege-alexander-fossa</acast:episodeUrl>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmRbkUlg2iR8fDtnl1O71B2N8B7jZZH+7YdsHlGFxMJ/JB5ewwSWwnDfITsERRlXnRPdjbJm7d4qQ2rUK1Oh2E65gYDhVAjVZ14DHwOhC8Pz9i+jargxr+Z+jVE9yJC778zhTQHU6gZEVV13nQX7pAdNB4u1MbNygBgy4VtStsTGZDTm4svZmzStw+pmjnI3CvDVSxJNi0XoecF251QwStf3FCehPgXi9xT2YyHfevWty1Dfy+qf99Ti5ryH5YZ2x3wKjBbS+Ohg+LN/mYn4xhNS/36knBUdvTBOGiWX5XfB9i4Z5LVGKVTE93sCbtS2kYg==]]></acast:settings>
			<itunes:subtitle>Hematologi teamet i Bristol Myers Squibb oppsøker miljøet for å lære mer om reisen fra forskning til pasient.</itunes:subtitle>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:season>1</itunes:season>
			<itunes:episode>1</itunes:episode>
			<itunes:image href="https://assets.pippa.io/shows/6140941ffd9dbd0012866cbb/1656411788818-e198d4b095595685c6b9cae88ecb6f44.jpeg"/>
			<description><![CDATA[<p>Hva betyr det å bli syk med blodkreft i dag? Hvem er legen som behandler pasienten og hva bidrar legene med for at pasienter skal få den beste behandlingen som finnes?&nbsp;&nbsp;</p><p>Hvorfor er det så vanskelig å prioritere ny og innovativ behandling i Norge og hvem er beslutningstakerne?</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Hva betyr det å bli syk med blodkreft i dag? Hvem er legen som behandler pasienten og hva bidrar legene med for at pasienter skal få den beste behandlingen som finnes?&nbsp;&nbsp;</p><p>Hvorfor er det så vanskelig å prioritere ny og innovativ behandling i Norge og hvem er beslutningstakerne?</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
    	<itunes:category text="Education"/>
    </channel>
</rss>
